Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL) is set to close, following approval from the Government of India. The administrative control of the company, under the Department of Biotechnology, Ministry of Science and Technology, has been officially transferred. This development signals a major shift for the corporation and its stakeholders. Further details regarding the implications of this closure are expected.
Government Approves Closure of BIBCOL
Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL) will be closing down. The Government of India has officially approved the closure of the company, which operated under the administrative control of the Department of Biotechnology, Ministry of Science and Technology. This significant decision was communicated as per the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Operational Shift and Future Implications
The approval marks a pivotal moment for BIBCOL, indicating a substantial change in its operational status. The information regarding the closure has been formally submitted, and stakeholders are requested to take this update on record. Further details or announcements regarding the winding-up process and its implications are anticipated.
The company’s communication to the Bombay Stock Exchange references a prior communication dated September 17, 2026, from the Department of Biotechnology, highlighting the official progression of this decision.
Source: BSE
